1. Alcigir ME, Atalay Vural S. Evaluation of liver and heart lesions induced by experimental fowl adenovirus-4 infection in broilers and virus detection by immunohistochemistry, immunofluorescence and in situ PCR. Revue Méd Vét. 2013; 164:348–357.
2. Chamary JV, Hurst LD. The price of silent mutations. Sci Am. 2009; 300:46–53.
Article
3. Choi YK, Kim CJ. Sequence analysis of canine LINE-1 elements and p53 gene in canine transmissible venereal tumor. J Vet Sci. 2002; 3:285–292.
Article
4. Fonseca LS, Mota LSLS, Colodel MM, Ferreira I, Brandão CVS, Rocha NS. Spontaneous canine transmissible venereal tumor: association between different phenotypes and the insertion LINE-1/c-myc. Rev Colom Cienc Pecua. 2012; 25:402–408.
5. Goldschmidt MH, Hendrick MJ. Tumors of the skin and soft tissues. In : Meuten DJ, editor. Tumors of Domestic Animals. 4th ed. Ames: Iowa State Press;2002. p. 115–117.
6. Gonzalez CM, Griffey SM, Naydan DK, Flores E, Cepeda R, Cattaneo G, Madewell BR. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy. J Comp Pathol. 2000; 122:241–248.
Article
7. Liao KW, Lin ZY, Pao HN, Kam SY, Wang FI, Chu RM. Identification of canine transmissible venereal tumor cells using in situ polymerase chain reaction and the stable sequence of the long interspersed nuclear element. J Vet Diagn Invest. 2003; 15:399–406.
Article
8. McEntee K, Nielsen SW. Tumors of the female genital tract. Bull World Health Organ. 1976; 53:217–226.
9. Montoya-Durango DE, Liu Y, Teneng I, Kalbfleisch T, Lacy ME, Steffen MC, Ramos KS. Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat Res. 2009; 665:20–28.
Article
10. Mozos E, Méndez A, Gómez-Villamandos JC, Martín De Las Mulas J, Pérez J. Immunohistochemical characterization of canine transmissible venereal tumor. Vet Pathol. 1996; 33:257–263.
Article
11. Mukaratirwa S, Gruys E. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review. Vet Q. 2003; 25:101–111.
Article
12. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. Bioessays. 2003; 25:577–588.
Article
13. Nak D, Nak Y, Cangul IT, Tuna B. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs. J Vet Med A Physiol Pathol Clin Med. 2005; 52:366–370.
Article
14. Pérez J, Day MJ, Mozos E. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth. Vet Immunol Immunopathol. 1998; 64:133–147.
Article
15. Richardson RC. Canine transmissible veneral tumor. Compend Contin Educ Prac Vet. 1981; 3:951–956.
16. Rogers KS. Transmissible venereal tumor. Compend Contin Educ Pract Vet. 1997; 19:1036–1045.
17. Scarpelli KC, Valladão ML, Metze K. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy. Vet J. 2010; 183:362–363.
Article
18. Schlafer DH, Miller RB. Female genital system. In : Maxie MG, editor. Jubb, Kennedy, and Palmer's Pathology of Domestic Animals. 5th ed. New York: Elsevier Saunders;2007. p. 429–564.
19. Smit AF. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev. 1999; 9:657–663.
Article
20. Trompieri-Silveira AC, Gerardi D, Mouro JV, Costa MT, Alessi AC. Immunohistochemical expression of B and T-lymphocytes and TGF-β in experimentally transplanted canine venereal tumor. Cienc Rural. 2009; 39:1148–1154.
Article
21. Wilkins AS. The enemy within: an epigenetic role of retrotransposons in cancer initiation. Bioessays. 2010; 32:856–865.
Article